Neonatal management and outcome in complicated monochorionic twins: What have we learned in the past decade and what should you know?

Monoamniotic twins Monochorionic twins Selective fetal growth restriction Twin anemia polycythemia sequence Twin-twin transfusion syndrome

Journal

Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 03 02 2022
revised: 28 03 2022
accepted: 28 03 2022
pubmed: 7 5 2022
medline: 23 11 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Monochorionic (MC) twin pregnancies are at increased risk of neonatal morbidity and mortality due to the shared placenta with vascular connections that can give rise to various complications, including twin-twin transfusion syndrome, twin anemia polycythemia sequence (TAPS), selective fetal growth restriction, and other hematological imbalances at birth. Each complication presents its own challenges and considerations in the neonatal period. Measurement of hemoglobin levels and reticulocyte count is required to establish a correct diagnosis. Placenta dye injection is needed to properly distinguish between the various conditions. Risk factors for adverse outcome in MC twins include prematurity, severe cerebral injury, and the type of MC pregnancy complication. We, therefore, recommend cerebral ultrasound examinations in all complicated MC twins at birth to rule out a severe brain injury. Lastly, we strongly encourage screening for hearing loss using automated auditory brainstem response in all spontaneous TAPS donors to prevent permanent speech development delay.

Identifiants

pubmed: 35513960
pii: S1521-6934(22)00055-4
doi: 10.1016/j.bpobgyn.2022.03.016
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-228

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Sophie G Groene (SG)

Division of Neonatology, Willem-Alexander Children's Hospital, Dept. of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands; Division of Molecular Epidemiology, Dept. of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: S.G.Groene@lumc.nl.

Lisanne S A Tollenaar (LSA)

Division of Fetal Therapy, Dept. of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.

Johanna M Middeldorp (JM)

Division of Fetal Therapy, Dept. of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.

Enrico Lopriore (E)

Division of Neonatology, Willem-Alexander Children's Hospital, Dept. of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH